Why is P & G Health Ltd falling/rising?

As of 25-Aug, Procter & Gamble Health Ltd's stock price is currently at 6,455.75, reflecting a decline of 118.05 points or 1.8%. The stock has recently underperformed its sector by 2.21% and has fallen after two consecutive days of gains, touching an intraday low of Rs 6350, which represents a 3.4% decrease. Despite this drop, the stock has shown strong performance over the past week, month, and year, with returns of 3.91%, 10.70%, and 24.03%, respectively. The company has maintained a high management efficiency with a return on equity (ROE) of 32.32% and has reported positive results for the last four consecutive quarters, indicating strong operational performance. However, the stock is facing risks due to its high valuation and relatively poor long-term growth in net sales and operating profit.
In the broader market context, Procter & Gamble Health Ltd has outperformed the benchmark Sensex in the short term, with a 1-week return of 3.91% compared to the Sensex's 0.45%. This suggests that while the stock is currently experiencing a decline, it has been performing well relative to the market over recent periods. The high institutional holdings at 21.15% may provide some support, as these investors typically have better resources to analyze the company's fundamentals. However, the stock's recent price movement may reflect concerns over its valuation and growth potential, which could be influencing investor sentiment negatively despite its strong historical performance.